BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16675472)

  • 1. A novel anticancer effect of garlic derivatives: inhibition of cancer cell invasion through restoration of E-cadherin expression.
    Chu Q; Ling MT; Feng H; Cheung HW; Tsao SW; Wang X; Wong YC
    Carcinogenesis; 2006 Nov; 27(11):2180-9. PubMed ID: 16675472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-allylcysteine, a water-soluble garlic derivative, suppresses the growth of a human androgen-independent prostate cancer xenograft, CWR22R, under in vivo conditions.
    Chu Q; Lee DT; Tsao SW; Wang X; Wong YC
    BJU Int; 2007 Apr; 99(4):925-32. PubMed ID: 17155983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Garlic-derived S-allylmercaptocysteine is a novel in vivo antimetastatic agent for androgen-independent prostate cancer.
    Howard EW; Ling MT; Chua CW; Cheung HW; Wang X; Wong YC
    Clin Cancer Res; 2007 Mar; 13(6):1847-56. PubMed ID: 17363541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel function of Id-1 in mediating the anticancer responses of SAMC, a water-soluble garlic derivative, in human bladder cancer cells.
    Hu H; Zhang XP; Wang YL; Chua CW; Luk SU; Wong YC; Ling MT; Wang XF; Xu KX
    Mol Med Rep; 2011; 4(1):9-16. PubMed ID: 21461556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-Allylcysteine reduces breast tumor cell adhesion and invasion.
    Gapter LA; Yuin OZ; Ng KY
    Biochem Biophys Res Commun; 2008 Mar; 367(2):446-51. PubMed ID: 18190785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of apoptosis by S-allylmercapto-L-cysteine, a biotransformed garlic derivative, on a human gastric cancer cell line.
    Lee Y
    Int J Mol Med; 2008 Jun; 21(6):765-70. PubMed ID: 18506370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
    Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
    Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTY720, a fungus metabolite, inhibits invasion ability of androgen-independent prostate cancer cells through inactivation of RhoA-GTPase.
    Zhou C; Ling MT; Kin-Wah Lee T; Man K; Wang X; Wong YC
    Cancer Lett; 2006 Feb; 233(1):36-47. PubMed ID: 16473668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of HDAC1 in E-cadherin expression in prostate cancer cells; its implication for cell motility and invasion.
    Kim NH; Kim SN; Kim YK
    Biochem Biophys Res Commun; 2011 Jan; 404(4):915-21. PubMed ID: 21184735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of a novel docetaxel sensitizer, garlic-derived S-allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer.
    Howard EW; Lee DT; Chiu YT; Chua CW; Wang X; Wong YC
    Int J Cancer; 2008 May; 122(9):1941-8. PubMed ID: 18183597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfection of E-cadherin cDNA in human lung tumor cells reduces invasive potential of tumors.
    Moersig W; Horn S; Hilker M; Mayer E; Oelert H
    Thorac Cardiovasc Surg; 2002 Feb; 50(1):45-8. PubMed ID: 11847604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-expression of survivin is a factor responsible for differential responses of ovarian cancer cells to S-allylmercaptocysteine (SAMC).
    Wu J; Zhao S; Zhang J; Qu X; Jiang S; Zhong Z; Zhang F; Wong Y; Chen H
    Exp Mol Pathol; 2016 Apr; 100(2):294-302. PubMed ID: 26896649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells.
    Fernández-Martínez AB; Bajo AM; Sánchez-Chapado M; Prieto JC; Carmena MJ
    Prostate; 2009 May; 69(7):774-86. PubMed ID: 19189304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines.
    Yang AD; Fan F; Camp ER; van Buren G; Liu W; Somcio R; Gray MJ; Cheng H; Hoff PM; Ellis LM
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4147-53. PubMed ID: 16857785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative effects of S-allylmercaptocysteine on colon cancer cells when tested alone or in combination with sulindac sulfide.
    Shirin H; Pinto JT; Kawabata Y; Soh JW; Delohery T; Moss SF; Murty V; Rivlin RS; Holt PR; Weinstein IB
    Cancer Res; 2001 Jan; 61(2):725-31. PubMed ID: 11212275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of E-cadherin by small activating RNA inhibits cell invasion and migration in 5637 human bladder cancer cells.
    Mao Q; Li Y; Zheng X; Yang K; Shen H; Qin J; Bai Y; Kong D; Jia X; Xie L
    Biochem Biophys Res Commun; 2008 Oct; 375(4):566-70. PubMed ID: 18725195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide (As2O3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo.
    Yu J; Qian H; Li Y; Wang Y; Zhang X; Liang X; Fu M; Lin C
    Gynecol Oncol; 2007 Aug; 106(2):400-6. PubMed ID: 17512576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor.
    DiFeo A; Narla G; Camacho-Vanegas O; Nishio H; Rose SL; Buller RE; Friedman SL; Walsh MJ; Martignetti JA
    Oncogene; 2006 Sep; 25(44):6026-31. PubMed ID: 16702959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S-allylcysteine modulates the expression of E-cadherin and inhibits the malignant progression of human oral cancer.
    Tang FY; Chiang EP; Chung JG; Lee HZ; Hsu CY
    J Nutr Biochem; 2009 Dec; 20(12):1013-20. PubMed ID: 19157822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor effect of ascorbic acid, lysine, proline, arginine, and epigallocatechin gallate on prostate cancer cell lines PC-3, LNCaP, and DU145.
    Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():251-64. PubMed ID: 17564322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.